AstraZeneca Deepens China Bet With New Asthma and Cancer Drug Deals

Posted on by http://wealthcreation.club
‼️ AstraZeneca has teamed with Chinese innovators on a range of medicines. It recently licensed an inhaled drug for asthma and chronic obstructive pulmonary disease that’s code-named TQC3721, from Sino BioPharmaceutical , as well as the oral targeted cancer drug Zegfrovy from Dizal Pharmaceutical . It is developing oral cancer drug Orpathys, with Hutchmed .
Unknown's avatar

Published by http://wealthcreation.club

http://wealthcreation.club—We are educating regular people about how to be able to make more money in a disciplined way

Leave a comment